Medline (MDLN) Stock Price & Analysis

MDLN$39.16+1.48 +3.93%
Medical - Instruments & SuppliesLarge Cap
Compare
Market cap$34.41BEnterprise value$33.11BRevenue (TTM)$30.68BMarket positionTop 25%

Score

47
Neutral
Value
42
Quality
50
Growth
49

AI Analysis

Snapshot

Medline scores 47/100, but the multiple is asking a lot (P/E 59.3, rich vs its own history). Under the hood: P/E 59.3, rich vs its own history, plus revenue compounding ~10% annually over recent years. Street targets still imply ~13% upside.

Price History

Bullish (65+)Neutral (45–64)Bearish (<45)

Score Breakdown

Market percentile scores loading…

Value

42
PE Ratio (F)–
PEG Ratio–
Free Cashflow Yield %–
EV/EBITDA Ratio–
Discount vs All Time Peak–
Discount vs 1Y Peak–

Growth

49
Earnings Forecast–
Last 3M Earnings Growth %–
12M Revenue Growth %–
12M Earnings Growth %–
5 YR CAGR % Earnings–
Analyst Price Forecast–

Quality

50
FCF Margin %–
Net Debt / EBITDA–
Operating Margin %–
Operating Margin Growth %–
ROCE %–
Current Ratio–

Financial Summary

Medline Inc. (MDLN) last printed $39.16. Equity value is $34.41B. Trailing earnings multiple 48.53. The revenue row is reported history. Targets and ratings are on the forecast page.

Financials

2022202320242025
$21.45B$23.23B$25.51B$28.43B

About

Medline Inc. is a global manufacturer of medical and surgical products, catering to a broad spectrum of healthcare providers. Their clientele includes hospitals, surgical centers, physician practices, post-acute care facilities, and nursing homes, both domestically and worldwide. The company's operations are divided into two primary divisions: the Medline Brand and Supply Chain Solutions. The Medline Brand division focuses on the production and sourcing of its proprietary medical products, categorized into three key areas: Within Frontline Care, Medline provides a wide array of patient-facing medical and surgical items. This encompasses essentials like wound care treatments, examination gloves, skin and incontinence products, sanitation supplies, various textiles, hand sanitizers, durable medical equipment (DME), patient-specific plastic goods, and decolonization and infection control solutions. The Surgical Solutions category delivers comprehensive product lines for operating rooms and perioperative settings. Offerings range from surgical procedure trays, drapes, and gowns to personal protective equipment (PPE), sterile wraps, various surgical instruments, specialized surgeon's gloves, complete procedure kits, and orthopedic implants. Finally, Laboratory and Diagnostics supplies critical solutions for clinical testing and analysis. This includes point-of-care testing devices, analytical instruments, laboratory consumables, advanced diagnostic equipment, vital signs monitoring systems, and products for anatomic pathology and phlebotomy. The Supply Chain Solutions segment is responsible for sourcing and distributing a diverse portfolio of third-party products, including those from well-known national brands. Beyond distribution, this segment offers comprehensive logistics and supply chain optimization services to clients both domestically and internationally. These optimization services encompass strategic consulting, outsourced management of warehousing and technology, specialized "put-away-ready" packaging, third-party logistics (3PL), inventory rationalization strategies, and efficient route planning. Established in 1966, Medline Inc. maintains its headquarters in Northfield, Illinois.

Medline (MDLN) Stock Price & Analysis

MDLN price $39.16 +1.48 +3.93%

Ticker
MDLN
Price
$39.16
Change
+1.48 +3.93%
Market cap
$34.41B
P/E
48.53
Forward P/E
24.92
Dividend yield
0.00%
Beta
-0.39
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Stocklytics score
47
Value
42
Quality
50
Growth
49

Stocklytics score rationale: value 42, quality 50, growth 49.

AI Score 65. Medline Inc. has a market cap of $35.4 billion and a price of $40.35, but its high price-to-earnings ratio of approximately 59.3 suggests overvaluation

Insights · Forecast · Financials · Learn

Stocklytics home · Screener